James J. Dignam - Researcher Profile

Publications

3 shown

Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer

Bernard Fisher , James J. Dignam , Birol Emir +10 more

Findings from this and other NSABP studies indicate that patients with breast cancer who meet NSABP protocol criteria, regardless of age, lymph node status, tumor size, or estro...

1997 JNCI Journal of the National Cancer I... 521 citations

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

Bernard Fisher , Jong‐Hyeon Jeong , John Bryant +4 more

2004 The Lancet 357 citations

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison , Andy Trotti , Jonathan Harris +24 more

2018 The Lancet 1218 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 2,096
Institution: University of Pittsburgh

External Links

Google Scholar

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.